TY  - GEN
AU  - Del Campo,Josep M
AU  - Matulonis,Ursula A
AU  - Malander,Susanne
AU  - Provencher,Diane
AU  - Mahner,Sven
AU  - Follana,Philippe
AU  - Waters,Justin
AU  - Berek,Jonathan S
AU  - Woie,Kathrine
AU  - Oza,Amit M
AU  - Canzler,Ulrich
AU  - Gil-Martin,Marta
AU  - Lesoin,Anne
AU  - Monk,Bradley J
AU  - Lund,Bente
AU  - Gilbert,Lucy
AU  - Wenham,Robert M
AU  - Benigno,Benedict
AU  - Arora,Sujata
AU  - Hazard,Sebastien J
AU  - Mirza,Mansoor R
TI  - Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial
SN  - 1527-7755
PY  - 2020///0624
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Indazoles
KW  - administration & dosage
KW  - Maintenance Chemotherapy
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - drug therapy
KW  - Organoplatinum Compounds
KW  - Ovarian Neoplasms
KW  - Piperidines
KW  - Poly(ADP-ribose) Polymerase Inhibitors
KW  - Progression-Free Survival
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.18.02238
ER  -